Worst performer was CWR:Ceres Power Holdings dropping 11% and continuing a gradual drift downwards on lack of news.
TLOU:Tlou Energy was going well but has dropped 6% this week and TRX:Tissue Regenix is in freefall, dropping another 5% to go 69% down.
OPTI:Optibiotix also fell 5% but the impact was more drastic. A 3p drop cost the portfolio £1,350 and accounts for most of the drop this week.
IQE:IQE had a flat week climbing 1% in my SIPP but 7% of cost price in my ISA
Share of the Week is CAML:Central Asia Metals, climbing 10% and now 55% up on cost price making potential profit of £2,535
The buffer has almost halved over a couple of weeks.
The ISA and share accounts look like this
Weekly Change | |||
Cash | £66.20 | -£3.75 | |
Portfolio cost | £44,426.84 | +£0 | |
Portfolio sell value (bid price - commission) | £47,609.53 | (+7.2%) | -£1,308.60 |
Potential profits | £10,528.43 | -£408.40 | |
Yr 3 Dividends | £34.11 | +£0 | |
Yr 3 Profit from sales | £585.38 | +£0 | |
Yr 3 Average monthly cash profit | £134.69 | (3.6%) | -£8.87 |
Total Dividends | £1,213.16 | +£0 | |
Total Profit from sales | £7,297.85 | +£0 | |
Average monthly cash profit | £298.03 | (8.0%) | -£2.60 |
(Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to monthly fees. Potential profits not hit too badly, but OPTI:Optibiotix is back to making a loss and most of the £1,308 was down to that. Performance is looking really poor so I may contemplate a pre-Christmas sale to try and turn it aroiund.
I should be happy that this account is still in profit after the first 2 years in the red, but it really highlights my dependence on IQE:IQE as I'd be well in the red without that.
The SIPP looks like this after week 106
Weekly Change | |||
Cash | £8.66 | -£10.65 | |
Portfolio cost | £26,007.03 | +£0 | |
Portfolio sell value (bid price - commission) | £27,844.00 | (7.1%) | -£284.49 |
Potential profits | £3,607.26 | -£73.75 | |
Yr 3 Dividends | £0 | +£0 | |
Yr 3 Profit from sales | £0 | +£0 | |
Yr 3 Average monthly cash profit | £0 | (0%) | +£0 |
Total Dividends | £916.10 | +£0 | |
Total Profit from sales | £8,925.19 | +£0 | |
Average monthly cash profit | £395.84 | (18.3%) | -£4.21 |
(Sold stocks profit + Dividends - Fees / Months) |
Cash fees taken leaving not enough to cover next month, but damage to the portfolio fairly limited, especially compared th last week. Negatives were counter-acted by a 10% rise in CAML:Central Asia Metals.
Much more serious drop - I really need OPTI:Optibiotix to recover.
The trading account looks like this after week 72
Weekly Change | |||
Cash | £79.63 | +£0 | |
Portfolio cost | £486.05 | +£0 | |
Portfolio sell value (bid price - commission) | £260.49 | (-46.4%) | +£19.46 |
Potential profits | £0 | +£0 | |
Dividends | £1.15 | +£0 | |
Profit from sales | -£22.85 | +£0 | |
Average monthly cash profit | -£1.31 | (-3.2%) | +£0.01 |
(Sold stocks profit + Dividends - Fees / Months) |
The best performaong account this week! News of a big contract win for REDS:RedstoneConnect resulted in a 4% climb but nowhere near enough to get rid.
Still looks rubbish
TRK:Torotrak went into administration this week. Hopefully they will sell off some assets and return something to shareholders. I'm quite looking forward to them not being in my portfolio any more.
Next week may see interim results for IQE:IQE. The share price isn't rising into it, but may rise as a result of it. I am tempted to sell something in order to top up a few more before results, and drop my average price of OPTI:Optibiotix now it's dipped back below 70p. What to sell?
No comments:
Post a Comment